These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 10901752)
1. The prospects for antisense therapy. Gewirtz AM Hosp Pract (1995); 1999 Sep; 34(10):97-107; quiz 141. PubMed ID: 10901752 [TBL] [Abstract][Full Text] [Related]
2. Antisense therapeutics in chronic myeloid leukaemia: the promise, the progress and the problems. Clark RE Leukemia; 2000 Mar; 14(3):347-55. PubMed ID: 10720125 [TBL] [Abstract][Full Text] [Related]
6. Antisense oncogene and tumor suppressor gene therapy of cancer. Zhang WW J Mol Med (Berl); 1996 Apr; 74(4):191-204. PubMed ID: 8740650 [TBL] [Abstract][Full Text] [Related]
7. Is antisense gene therapy a step in the right direction in the control of hypertension? Raizada MK; Katovich MJ; Wang H; Berecek KH; Gelband CH Am J Physiol; 1999 Aug; 277(2):H423-32. PubMed ID: 10444465 [No Abstract] [Full Text] [Related]
8. Gene therapy for gastric cancer: problems and prospects. Steele RJ; Lane DP Surg Oncol; 2000 Jul; 9(1):13-6. PubMed ID: 11525301 [No Abstract] [Full Text] [Related]
9. [Molecular targeting therapy for chronic myelogenous leukemia]. Ono R Nihon Naika Gakkai Zasshi; 2003 May; 92(5):884-9. PubMed ID: 12808916 [No Abstract] [Full Text] [Related]
10. Gene therapy for AIDS using retroviral mediated gene transfer to deliver HIV-1 antisense TAR and transdominant Rev protein genes to syngeneic lymphocytes in HIV-1 infected identical twins. Morgan RA; Walker R Hum Gene Ther; 1996 Jun; 7(10):1281-306. PubMed ID: 8793552 [No Abstract] [Full Text] [Related]
18. [Recent progress in diagnosis of and therapy for patients with leukemia]. Ueda T Nihon Naika Gakkai Zasshi; 2004 Mar; 93(3):574-9. PubMed ID: 15052823 [No Abstract] [Full Text] [Related]
19. Sense, antisense, nonsense: where's the right way? Bricca G J Mol Med (Berl); 1995 Aug; 73(8):417-9. PubMed ID: 8528744 [TBL] [Abstract][Full Text] [Related]
20. Dasatinib: a tyrosine kinase inhibitor for the treatment of chronic myelogenous leukemia and philadelphia chromosome-positive acute lymphoblastic leukemia. Steinberg M Clin Ther; 2007 Nov; 29(11):2289-308. PubMed ID: 18158072 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]